Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.690
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $86.56 million as of December 20, 2024. Its market cap has decreased by -22.64% in one year.

Market Cap
86.56M
Enterprise Value
66.05M
1-Year Change
-22.64%
Ranking
Category
Stock Price
$2.69

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $86.56M, an increase of 4.04%. That is a compound annual growth rate of 0.15%.

History

DateMarket Cap% Change
Dec 20, 202486.60M-28.19%
Dec 29, 2023120.60M-7.44%
Dec 30, 2022130.30M46.40%
Dec 31, 202189.00M21.92%
Dec 31, 202073.00M10.11%
Dec 31, 201966.30M-10.04%
Dec 31, 201873.70M106.44%
Dec 29, 201735.70M-24.52%
Dec 30, 201647.30M79.85%
Dec 31, 201526.30M10.04%
Dec 31, 201423.90M-39.34%
Dec 31, 201339.40M18.32%
Dec 31, 201233.30M73.44%
Dec 30, 201119.20M-39.81%
Dec 31, 201031.90M-65.14%
Dec 31, 200991.50M61.95%
Dec 31, 200856.50M-63.00%
Dec 31, 2007152.70M62.27%
Dec 29, 200694.10M31.24%
Dec 30, 200571.70M-0.42%
Dec 31, 200472.00M94.07%
Dec 31, 200337.10M183.21%
Dec 31, 200213.10M-52.88%
Dec 31, 200127.80M-35.94%
Dec 29, 200043.40M-11.07%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
HilleVax 88.27M
Fractyl Health 87.54M
OptimizeRx 87.50M
LENSAR 87.11M
Skye Bioscience 86.77M
Coya Therapeutics 86.21M
Monogram Technologies 86.12M
CytomX Therapeutics 86.08M
Market Cap Rankings